APA (7th ed.) Citation

K, P., AC, N., M, C., TG, P., P, V. B., JT, P., . . . PE, V. (2014). Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults. Clinical and vaccine immunology : CVI, 21(5), 651. https://doi.org/10.1128/CVI.00807-13

Chicago Style (17th ed.) Citation

K, Pauksens, Nilsson AC, Caubet M, Pascal TG, Van Belle P, Poolman JT, Vandepapelière PG, Verlant V, and Vink PE. "Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02V in Elderly Adults." Clinical and Vaccine Immunology : CVI 21, no. 5 (2014): 651. https://doi.org/10.1128/CVI.00807-13.

MLA (9th ed.) Citation

K, Pauksens, et al. "Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02V in Elderly Adults." Clinical and Vaccine Immunology : CVI, vol. 21, no. 5, 2014, p. 651, https://doi.org/10.1128/CVI.00807-13.